JEFFREY M LEIDEN

CIK 1242825 · Executive Chairman · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.90M

Companies

4

Total Filings

106

Lifetime Open-Market Net

-$544.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ODTX Director 298,896 $100.0K 1 2026-05-11
VRTX Executive Chairman 35,237 $444.93 $15.68M -$543.95M 88 2026-02-26
DGX Director 6,000 $203.06 $1.22M -$890.2K 15 2018-05-30
MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Director $0 2 2008-05-15

Recent Filings · Page 10 of 11

106 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-02-11 VRTX Sell (S) −35,944 -$2.88M EDGAR
2014-02-07 VRTX Grant (A) +64,500 $645 EDGAR
2014-01-17 VRTX Mixed -$2.25M EDGAR
2013-12-12 VRTX Sell (S) −9,834 -$643.9K EDGAR
2013-08-01 VRTX Grant (A) $0 EDGAR
2013-02-07 VRTX Mixed +5,989 -$1.53M EDGAR
2012-07-26 VRTX Grant (A) $0 EDGAR
2011-12-16 VRTX Grant (A) +183,395 $1.8K EDGAR
2011-06-02 VRTX Grant (A) $0 EDGAR
2010-12-17 VRTX Grant (A) $0 EDGAR
Showing 91100 of 106
Page 10 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.